PPD Inc. (PPD): Price and Financial Metrics

PPD Inc. (PPD)

Today's Latest Price: $33.79 USD

0.09 (-0.27%)

Updated Nov 24 4:00pm

Add PPD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PPD Stock Price Chart Interactive Chart >

Price chart for PPD

PPD Price/Volume Stats

Current price $33.79 52-week high $37.51
Prev. close $33.88 52-week low $10.61
Day low $33.52 Volume 1,095,400
Day high $34.34 Avg. volume 1,380,432
50-day MA $34.86 Dividend yield N/A
200-day MA $28.99 Market Cap 11.81B

PPD Inc. (PPD) Company Bio

Pharmaceutical Product Development LLC is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Its services include contact services, discovery, early development, clinical development, laboratories, post-approval, PPD consulting and industry expertise. The firm operates in the therapeutic areas that include cardiovascular, critical care, dermatology, dental pain research, endocrine and metabolics, gastroenterology, hematology and oncology, immunology, infectious diseases, neuroscience, ophthalmology, respiratory and urology. The company was founded in 1985 by Fredric N. Eshelman and is headquartered in Wilmington, NC.

PPD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$33.79$0.9 -97%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for PPD Inc. To summarize, we found that PPD Inc ranked in the 6th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 97%. The most interesting components of our discounted cash flow analysis for PPD Inc ended up being:

  • The company's compound free cash flow growth rate over the past 0.78 years comes in at -0.29%; that's greater than only 4.94% of US stocks we're applying DCF forecasting to.
  • PPD Inc's weighted average cost of capital (WACC) is 9%; for context, that number is higher than 58.82% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), PPD Inc has a reliance on debt greater than 71.96% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of PPD Inc? See INFU, OSMT, PHG, CTLT, and LUMO.

PPD Latest News Stream

Event/Time News Detail
Loading, please wait...

PPD Latest Social Stream

Loading social stream, please wait...

View Full PPD Social Stream

Latest PPD News From Around the Web

Below are the latest news stories about PPD Inc that investors may wish to consider to help them evaluate PPD as an investment opportunity.

PPD prices secondary offering at $32.25

PPD (PPD) has priced its public offering of 38M common shares, to be sold by certain stockholders, including those affiliated with Hellman & Friedman and The Carlyle Group at $32.25/share.The selling stockholders granted the underwriters a 30-day option to purchase up to 5.7M shares. The Company will not receive any...

Seeking Alpha | September 17, 2020

PPD, Inc. (PPD) CEO David Simmons on Q2 2020 Results - Earnings Call Transcript

PPD, Inc. (PPD) Q2 2020 Earnings Conference Call August 5, 2020 08:30 ET Company Participants Nate Speicher - Senior Vice President, Finance David Simmons - Chairman and Chief Executive Officer Bill Sharbaugh - Chief Operating Officer Chris Scully - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research...

SA Transcripts on Seeking Alpha | August 10, 2020

Read More 'PPD' Stories Here

PPD Price Returns

1-mo -1.14%
3-mo 0.54%
6-mo 24.05%
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7628 seconds.